Press Center

Practices
Industries
Jurisdictions

Turkey’s Nuclear Regulatory Agency Has Tightened the Procedures for Modifying Equipment and Operating Procedures at Nuclear Facilities

27 October 2026

On October 2, 2026, the Official Gazette of Turkey (Resmî Gazete) published amendments by the Turkish Nuclear Regulatory Authority (Nükleer Düzenleme Kurumu, “NDK”) to the Regulation on Licensing Activities for Nuclear Facilities (“Licensing Regulation”) and the Regulation on the Management System for Nuclear Facilities, Radiation Facilities, and Radioactive Waste Management Facilities (“Management System Regulation”). Most of the amendments took effect on the date of publication. The new procedure for making changes at nuclear facilities (Article 41 of the Regulations on Licensing Activities) will take effect on January 2, 2027.

The amendments apply to organizations that carry out activities related to nuclear facilities based on NDK licensing documents (approvals, permits, and licenses). With regard to the Akkuyu NPP, the licensee is Akkuyu Nükleer A.Ş. Organizations within the Rosatom State Corporation that participate in the project as designers, equipment manufacturers, contractors, and service providers are indirectly affected by the amendments through the licensee’s processes and the terms of supply contracts.


The Middle East as Pharma’s New Mecca: a Closer Look at the UAE and Saudi Arabia

27 August 2026

Russian pharmaceutical manufacturers are increasingly looking toward the GCC and MENA regions. But "entering" and "establishing a foothold" are challenges of entirely different magnitudes.

The two key markets in the region — the UAE and Saudi Arabia — despite their undeniable appeal, require fundamentally different approaches.

Together with the Pharvestnik Magazine, Julia Kuzmenko, Counsel and Head of Regulatory Practice at Lidings, examined the nuances of the regulatory architecture in these two jurisdictions.


Lidings Law Firm Has Successfully Represented the Interests of Chinese Platform DEWU (Poizon) In A Dispute Over the Protection of POIZON Brand in Russia

22 May 2026

The Lidings team, led by Managing Partner Boris Malakhov and including Senior Associate Vladislav Ryabov, Associate Ivan Vasiliev, and Junior Associate Alena Troitskaya, advised the client in the dispute concerning intellectual property and brand protection in the Russian Federation.

The Pharmaceutical Industry in India: Patent Protection

01 April 2026 "Legal Insight" Magazine, April 2026

India has long and firmly established itself as the ‘pharmacy of the world’, as the country produces a fifth of all generics and provides affordable medicines to millions of people across the globe. However, India is now transitioning from copying innovative molecules to creating them. Amid the restructuring of global supply chains and strategic rapprochement with Russia, India is becoming both a battleground for fierce patent wars and a unique laboratory for joint research. How can Russian pharmaceutical companies establish intellectual property protection in a jurisdiction where the balance between the interests of pharmaceutical giants and the affordability of medicines for the population is enshrined in law? Boris Malakhov and Natalya Thotahewage analyse the key features of patenting and the prospects for technological alliances between Moscow and Delhi.

Two Years Since the Enactment of the Online Safety Act in Sri Lanka

19 January 2026

On 2 February 2024, the Online Safety Act, No. 9 of 2024 (hereinafter referred to as the “OSA”) was officially published in Sri Lanka. The OSA is a significant and controversial element of information security regulation in Sri Lanka. It establishes provisions prohibiting the communication of prohibited statements online and aims to prevent the use of online accounts and inauthentic online accounts for prohibited purposes.